Compile Data Set for Download or QSAR

Found 111 hits Enz. Inhib. hit(s) with Target = 'Tumor susceptibility gene 101 protein'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312337 (3,3'-((6S,27S,29aS,34aS,40S,43S,45aS)-25-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCC=CCCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C76H100N12O20S/c1-45-70(102)88-39-19-22-58(88)73(105)87-38-18-20-56(87)67(99)82-54(30-32-64(95)96)71(103)85(43-61(77)92)36-16-12-10-8-6-4-3-5-7-9-11-15-35-84(44-62(93)81-55(31-33-65(97)98)72(104)86-37-17-21-57(86)68(100)83-66(46(2)89)69(101)79-45)63(94)23-13-14-34-78-75(109)80-47-24-27-50-53(40-47)76(108-74(50)106)51-28-25-48(90)41-59(51)107-60-42-49(91)26-29-52(60)76/h7,9,24-29,40-42,45-46,54-58,66,89-91H,3-6,8,10-23,30-39,43-44H2,1-2H3,(H2,77,92)(H,79,101)(H,81,93)(H,82,99)(H,83,100)(H,95,96)(H,97,98)(H2,78,80,109)/t45-,46+,54-,55-,56-,57-,58-,66-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	1.10E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312338 (3,3'-((6S,26S,28aS,33aS,39S,42S,44aS)-24-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CC\C=C/CCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:28| Show InChI InChI=1S/C75H98N12O20S/c1-44-69(101)87-38-18-21-57(87)72(104)86-37-17-19-55(86)66(98)81-53(29-31-63(94)95)70(102)84(42-60(76)91)35-15-11-9-7-5-3-4-6-8-10-14-34-83(43-61(92)80-54(30-32-64(96)97)71(103)85-36-16-20-56(85)67(99)82-65(45(2)88)68(100)78-44)62(93)22-12-13-33-77-74(108)79-46-23-26-49-52(39-46)75(107-73(49)105)50-27-24-47(89)40-58(50)106-59-41-48(90)25-28-51(59)75/h8,10,23-28,39-41,44-45,53-57,65,88-90H,3-7,9,11-22,29-38,42-43H2,1-2H3,(H2,76,91)(H,78,100)(H,80,92)(H,81,98)(H,82,99)(H,94,95)(H,96,97)(H2,77,79,108)/b10-8-/t44-,45+,53-,54-,55-,56-,57-,65-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	1.70E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312339 (3,3'-((6S,27S,29aS,34aS,40S,43S,45aS)-25-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCCCC\C=C/CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:32| Show InChI InChI=1S/C76H100N12O20S/c1-45-70(102)88-39-19-22-58(88)73(105)87-38-18-20-56(87)67(99)82-54(30-32-64(95)96)71(103)85(43-61(77)92)36-16-12-10-8-6-4-3-5-7-9-11-15-35-84(44-62(93)81-55(31-33-65(97)98)72(104)86-37-17-21-57(86)68(100)83-66(46(2)89)69(101)79-45)63(94)23-13-14-34-78-75(109)80-47-24-27-50-53(40-47)76(108-74(50)106)51-28-25-48(90)41-59(51)107-60-42-49(91)26-29-52(60)76/h3-4,24-29,40-42,45-46,54-58,66,89-91H,5-23,30-39,43-44H2,1-2H3,(H2,77,92)(H,79,101)(H,81,93)(H,82,99)(H,83,100)(H,95,96)(H,97,98)(H2,78,80,109)/b4-3-/t45-,46+,54-,55-,56-,57-,58-,66-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	1.90E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312349 (3,3'-((6S,28S,30aS,35aS,41S,44S,46aS)-26-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCC\C=C/CCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:30| Show InChI InChI=1S/C77H102N12O20S/c1-46-71(103)89-40-20-23-59(89)74(106)88-39-19-21-57(88)68(100)83-55(31-33-65(96)97)72(104)86(44-62(78)93)37-17-13-11-9-7-5-3-4-6-8-10-12-16-36-85(45-63(94)82-56(32-34-66(98)99)73(105)87-38-18-22-58(87)69(101)84-67(47(2)90)70(102)80-46)64(95)24-14-15-35-79-76(110)81-48-25-28-51-54(41-48)77(109-75(51)107)52-29-26-49(91)42-60(52)108-61-43-50(92)27-30-53(61)77/h6,8,25-30,41-43,46-47,55-59,67,90-92H,3-5,7,9-24,31-40,44-45H2,1-2H3,(H2,78,93)(H,80,102)(H,82,94)(H,83,100)(H,84,101)(H,96,97)(H,98,99)(H2,79,81,110)/b8-6-/t46-,47+,55-,56-,57-,58-,59-,67-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	2.20E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312347 (3,3'-((6S,30S,32aS,37aS,43S,46S,48aS)-28-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCCCC\C=C/CCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:32| Show InChI InChI=1S/C79H106N12O20S/c1-48-73(105)91-42-22-25-61(91)76(108)90-41-21-23-59(90)70(102)85-57(33-35-67(98)99)74(106)88(46-64(80)95)39-19-15-13-11-9-7-5-3-4-6-8-10-12-14-18-38-87(47-65(96)84-58(34-36-68(100)101)75(107)89-40-20-24-60(89)71(103)86-69(49(2)92)72(104)82-48)66(97)26-16-17-37-81-78(112)83-50-27-30-53-56(43-50)79(111-77(53)109)54-31-28-51(93)44-62(54)110-63-45-52(94)29-32-55(63)79/h4,6,27-32,43-45,48-49,57-61,69,92-94H,3,5,7-26,33-42,46-47H2,1-2H3,(H2,80,95)(H,82,104)(H,84,96)(H,85,102)(H,86,103)(H,98,99)(H,100,101)(H2,81,83,112)/b6-4-/t48-,49+,57-,58-,59-,60-,61-,69-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	2.30E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312340 (3,3'-((6S,26S,28aS,33aS,39S,42S,44aS)-24-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCCC\C=C/CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:31| Show InChI InChI=1S/C75H98N12O20S/c1-44-69(101)87-38-18-21-57(87)72(104)86-37-17-19-55(86)66(98)81-53(29-31-63(94)95)70(102)84(42-60(76)91)35-15-11-9-7-5-3-4-6-8-10-14-34-83(43-61(92)80-54(30-32-64(96)97)71(103)85-36-16-20-56(85)67(99)82-65(45(2)88)68(100)78-44)62(93)22-12-13-33-77-74(108)79-46-23-26-49-52(39-46)75(107-73(49)105)50-27-24-47(89)40-58(50)106-59-41-48(90)25-28-51(59)75/h3-4,23-28,39-41,44-45,53-57,65,88-90H,5-22,29-38,42-43H2,1-2H3,(H2,76,91)(H,78,100)(H,80,92)(H,81,98)(H,82,99)(H,94,95)(H,96,97)(H2,77,79,108)/b4-3-/t44-,45+,53-,54-,55-,56-,57-,65-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	2.40E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312357 ((S)-5-amino-4-(2-((6S,9S,11aS,29aS,34aS)-18-((S)-1...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CC=CCCCCCCN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C71H90N12O18S/c1-41-65(95)82-34-15-19-54(82)68(98)83-35-14-18-53(83)67(97)78(39-57(87)76-50(62(72)92)27-28-60(90)91)30-10-6-4-3-5-7-11-31-79(40-59(89)80-32-12-16-51(80)63(93)77-61(42(2)84)64(94)74-41)66(96)52-17-13-33-81(52)58(88)20-8-9-29-73-70(102)75-43-21-24-46-49(36-43)71(101-69(46)99)47-25-22-44(85)37-55(47)100-56-38-45(86)23-26-48(56)71/h7,11,21-26,36-38,41-42,50-54,61,84-86H,3-6,8-10,12-20,27-35,39-40H2,1-2H3,(H2,72,92)(H,74,94)(H,76,87)(H,77,93)(H,90,91)(H2,73,75,102)/t41-,42+,50-,51-,52-,53-,54-,61-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	2.80E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312358 ((S)-5-amino-4-(2-((20aS,25aS,31S,34S,36aS,Z)-7-((S...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCC=CCCCCCCN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C73H94N12O18S/c1-43-67(97)84-36-17-21-56(84)70(100)85-37-16-20-55(85)69(99)80(41-59(89)78-52(64(74)94)29-30-62(92)93)32-12-8-6-4-3-5-7-9-13-33-81(42-61(91)82-34-14-18-53(82)65(95)79-63(44(2)86)66(96)76-43)68(98)54-19-15-35-83(54)60(90)22-10-11-31-75-72(104)77-45-23-26-48-51(38-45)73(103-71(48)101)49-27-24-46(87)39-57(49)102-58-40-47(88)25-28-50(58)73/h5,7,23-28,38-40,43-44,52-56,63,86-88H,3-4,6,8-22,29-37,41-42H2,1-2H3,(H2,74,94)(H,76,96)(H,78,89)(H,79,95)(H,92,93)(H2,75,77,104)/b7-5-/t43-,44+,52-,53-,54-,55-,56-,63-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.00E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312359 ((S)-5-amino-4-(2-((21aS,26aS,32S,35S,37aS)-7-((S)-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCCC=CCCCCCCN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C74H96N12O18S/c1-44-68(98)85-37-18-22-57(85)71(101)86-38-17-21-56(86)70(100)81(42-60(90)79-53(65(75)95)30-31-63(93)94)33-13-9-7-5-3-4-6-8-10-14-34-82(43-62(92)83-35-15-19-54(83)66(96)80-64(45(2)87)67(97)77-44)69(99)55-20-16-36-84(55)61(91)23-11-12-32-76-73(105)78-46-24-27-49-52(39-46)74(104-72(49)102)50-28-25-47(88)40-58(50)103-59-41-48(89)26-29-51(59)74/h4,6,24-29,39-41,44-45,53-57,64,87-89H,3,5,7-23,30-38,42-43H2,1-2H3,(H2,75,95)(H,77,97)(H,79,90)(H,80,96)(H,93,94)(H2,76,78,105)/b6-4-/t44-,45+,53-,54-,55-,56-,57-,64-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.10E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312342 (3-((24S,26aS,31aS,37S,40S,42aS)-22-(2-amino-2-oxoe...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCCCC\C=C/CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:23| Show InChI InChI=1S/C76H100N12O18S/c1-46-70(100)88-40-20-24-59(88)73(103)87-39-18-22-57(87)67(97)81-55(32-33-65(95)96)71(101)83(44-62(77)92)35-15-11-9-7-5-3-4-6-8-10-12-16-36-84(45-64(94)85-37-17-21-56(85)68(98)82-66(47(2)89)69(99)79-46)72(102)58-23-19-38-86(58)63(93)25-13-14-34-78-75(107)80-48-26-29-51-54(41-48)76(106-74(51)104)52-30-27-49(90)42-60(52)105-61-43-50(91)28-31-53(61)76/h3-4,26-31,41-43,46-47,55-59,66,89-91H,5-25,32-40,44-45H2,1-2H3,(H2,77,92)(H,79,99)(H,81,97)(H,82,98)(H,95,96)(H2,78,80,107)/b4-3-/t46-,47+,55-,56-,57-,58-,59-,66-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.10E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312348 (3,3'-((6S,29S,31aS,36aS,42S,45S,47aS)-27-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCCCC=CCCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C78H104N12O20S/c1-47-72(104)90-41-21-24-60(90)75(107)89-40-20-22-58(89)69(101)84-56(32-34-66(97)98)73(105)87(45-63(79)94)38-18-14-12-10-8-6-4-3-5-7-9-11-13-17-37-86(46-64(95)83-57(33-35-67(99)100)74(106)88-39-19-23-59(88)70(102)85-68(48(2)91)71(103)81-47)65(96)25-15-16-36-80-77(111)82-49-26-29-52-55(42-49)78(110-76(52)108)53-30-27-50(92)43-61(53)109-62-44-51(93)28-31-54(62)78/h5,7,26-31,42-44,47-48,56-60,68,91-93H,3-4,6,8-25,32-41,45-46H2,1-2H3,(H2,79,94)(H,81,103)(H,83,95)(H,84,101)(H,85,102)(H,97,98)(H,99,100)(H2,80,82,111)/b7-5-/t47-,48+,56-,57-,58-,59-,60-,68-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.20E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312360 ((S)-5-amino-4-(2-((22aS,27aS,33S,36S,38aS)-7-((S)-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCCC\C=C/CCCCCCN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:22| Show InChI InChI=1S/C75H98N12O18S/c1-45-69(99)86-38-19-23-58(86)72(102)87-39-18-22-57(87)71(101)82(43-61(91)80-54(66(76)96)31-32-64(94)95)34-14-10-8-6-4-3-5-7-9-11-15-35-83(44-63(93)84-36-16-20-55(84)67(97)81-65(46(2)88)68(98)78-45)70(100)56-21-17-37-85(56)62(92)24-12-13-33-77-74(106)79-47-25-28-50-53(40-47)75(105-73(50)103)51-29-26-48(89)41-59(51)104-60-42-49(90)27-30-52(60)75/h3,5,25-30,40-42,45-46,54-58,65,88-90H,4,6-24,31-39,43-44H2,1-2H3,(H2,76,96)(H,78,98)(H,80,91)(H,81,97)(H,94,95)(H2,77,79,106)/b5-3-/t45-,46+,54-,55-,56-,57-,58-,65-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.20E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312352 ((S)-5-amino-4-(2-((6S,23aS,28aS,34S,37S,39aS)-6-(2...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCC\C=C/CCCCCCN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:29| Show InChI InChI=1S/C73H94N12O20S/c1-42-67(99)84-35-16-19-55(84)70(102)85-36-15-18-54(85)69(101)82(41-59(90)78-51(64(74)96)27-29-61(92)93)33-13-9-7-5-3-4-6-8-12-32-81(40-58(89)79-52(28-30-62(94)95)68(100)83-34-14-17-53(83)65(97)80-63(43(2)86)66(98)76-42)60(91)20-10-11-31-75-72(106)77-44-21-24-47-50(37-44)73(105-71(47)103)48-25-22-45(87)38-56(48)104-57-39-46(88)23-26-49(57)73/h4,6,21-26,37-39,42-43,51-55,63,86-88H,3,5,7-20,27-36,40-41H2,1-2H3,(H2,74,96)(H,76,98)(H,78,90)(H,79,89)(H,80,97)(H,92,93)(H,94,95)(H2,75,77,106)/b6-4-/t42-,43+,51-,52-,53-,54-,55-,63-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.30E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312355 (3-((21S,23aS,28aS,34S,37S,39aS)-19-(2-amino-2-oxoe...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCC\C=C/CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:20| Show InChI InChI=1S/C73H94N12O18S/c1-43-67(97)85-37-17-21-56(85)70(100)84-36-15-19-54(84)64(94)78-52(29-30-62(92)93)68(98)80(41-59(74)89)32-12-8-6-4-3-5-7-9-13-33-81(42-61(91)82-34-14-18-53(82)65(95)79-63(44(2)86)66(96)76-43)69(99)55-20-16-35-83(55)60(90)22-10-11-31-75-72(104)77-45-23-26-48-51(38-45)73(103-71(48)101)49-27-24-46(87)39-57(49)102-58-40-47(88)25-28-50(58)73/h5,7,23-28,38-40,43-44,52-56,63,86-88H,3-4,6,8-22,29-37,41-42H2,1-2H3,(H2,74,89)(H,76,96)(H,78,94)(H,79,95)(H,92,93)(H2,75,77,104)/b7-5-/t43-,44+,52-,53-,54-,55-,56-,63-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.30E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312353 ((S)-5-amino-4-(2-((6S,24aS,29aS,35S,38S,40aS)-6-(2...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCC\C=C\CCCCCCN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,t:30| Show InChI InChI=1S/C74H96N12O20S/c1-43-68(100)85-36-17-20-56(85)71(103)86-37-16-19-55(86)70(102)83(42-60(91)79-52(65(75)97)28-30-62(93)94)34-14-10-8-6-4-3-5-7-9-13-33-82(41-59(90)80-53(29-31-63(95)96)69(101)84-35-15-18-54(84)66(98)81-64(44(2)87)67(99)77-43)61(92)21-11-12-32-76-73(107)78-45-22-25-48-51(38-45)74(106-72(48)104)49-26-23-46(88)39-57(49)105-58-40-47(89)24-27-50(58)74/h3,5,22-27,38-40,43-44,52-56,64,87-89H,4,6-21,28-37,41-42H2,1-2H3,(H2,75,97)(H,77,99)(H,79,91)(H,80,90)(H,81,98)(H,93,94)(H,95,96)(H2,76,78,107)/b5-3+/t43-,44+,52-,53-,54-,55-,56-,64-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.40E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312356 (3-((22S,24aS,29aS,35S,38S,40aS)-20-(2-amino-2-oxoe...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCC\C=C/CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:21| Show InChI InChI=1S/C74H96N12O18S/c1-44-68(98)86-38-18-22-57(86)71(101)85-37-16-20-55(85)65(95)79-53(30-31-63(93)94)69(99)81(42-60(75)90)33-13-9-7-5-3-4-6-8-10-14-34-82(43-62(92)83-35-15-19-54(83)66(96)80-64(45(2)87)67(97)77-44)70(100)56-21-17-36-84(56)61(91)23-11-12-32-76-73(105)78-46-24-27-49-52(39-46)74(104-72(49)102)50-28-25-47(88)40-58(50)103-59-41-48(89)26-29-51(59)74/h4,6,24-29,39-41,44-45,53-57,64,87-89H,3,5,7-23,30-38,42-43H2,1-2H3,(H2,75,90)(H,77,97)(H,79,95)(H,80,96)(H,93,94)(H2,76,78,105)/b6-4-/t44-,45+,53-,54-,55-,56-,57-,64-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.40E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312354 ((S)-5-amino-4-(2-((6S,25aS,30aS,36S,39S,41aS)-6-(2...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCCC\C=C/CCCCCCN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:31| Show InChI InChI=1S/C75H98N12O20S/c1-44-69(101)86-37-18-21-57(86)72(104)87-38-17-20-56(87)71(103)84(43-61(92)80-53(66(76)98)29-31-63(94)95)35-15-11-9-7-5-3-4-6-8-10-14-34-83(42-60(91)81-54(30-32-64(96)97)70(102)85-36-16-19-55(85)67(99)82-65(45(2)88)68(100)78-44)62(93)22-12-13-33-77-74(108)79-46-23-26-49-52(39-46)75(107-73(49)105)50-27-24-47(89)40-58(50)106-59-41-48(90)25-28-51(59)75/h3-4,23-28,39-41,44-45,53-57,65,88-90H,5-22,29-38,42-43H2,1-2H3,(H2,76,98)(H,78,100)(H,80,92)(H,81,91)(H,82,99)(H,94,95)(H,96,97)(H2,77,79,108)/b4-3-/t44-,45+,53-,54-,55-,56-,57-,65-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.50E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312343 (3-((23S,25aS,30aS,36S,39S,41aS-21-(2-amino-2-oxoet...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCCC\C=C/CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:22| Show InChI InChI=1S/C75H98N12O18S/c1-45-69(99)87-39-19-23-58(87)72(102)86-38-17-21-56(86)66(96)80-54(31-32-64(94)95)70(100)82(43-61(76)91)34-14-10-8-6-4-3-5-7-9-11-15-35-83(44-63(93)84-36-16-20-55(84)67(97)81-65(46(2)88)68(98)78-45)71(101)57-22-18-37-85(57)62(92)24-12-13-33-77-74(106)79-47-25-28-50-53(40-47)75(105-73(50)103)51-29-26-48(89)41-59(51)104-60-42-49(90)27-30-52(60)75/h3,5,25-30,40-42,45-46,54-58,65,88-90H,4,6-24,31-39,43-44H2,1-2H3,(H2,76,91)(H,78,98)(H,80,96)(H,81,97)(H,94,95)(H2,77,79,106)/b5-3-/t45-,46+,54-,55-,56-,57-,58-,65-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.50E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312341 (3,3'-((6S,25S,27aS,32aS,38S,41S,43aS)-23-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCC\C=C/CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:30| Show InChI InChI=1S/C74H96N12O20S/c1-43-68(100)86-37-17-20-56(86)71(103)85-36-16-18-54(85)65(97)80-52(28-30-62(93)94)69(101)83(41-59(75)90)34-14-10-8-6-4-3-5-7-9-13-33-82(42-60(91)79-53(29-31-63(95)96)70(102)84-35-15-19-55(84)66(98)81-64(44(2)87)67(99)77-43)61(92)21-11-12-32-76-73(107)78-45-22-25-48-51(38-45)74(106-72(48)104)49-26-23-46(88)39-57(49)105-58-40-47(89)24-27-50(58)74/h3,5,22-27,38-40,43-44,52-56,64,87-89H,4,6-21,28-37,41-42H2,1-2H3,(H2,75,90)(H,77,99)(H,79,91)(H,80,97)(H,81,98)(H,93,94)(H,95,96)(H2,76,78,107)/b5-3-/t43-,44+,52-,53-,54-,55-,56-,64-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	3.80E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312345 (3-((20S,22aS,27aS,33S,36S,38aS)-18-(2-amino-2-oxoe...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CC\C=C/CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:19| Show InChI InChI=1S/C72H92N12O18S/c1-42-66(96)84-36-16-20-55(84)69(99)83-35-14-18-53(83)63(93)77-51(28-29-61(91)92)67(97)79(40-58(73)88)31-11-7-5-3-4-6-8-12-32-80(41-60(90)81-33-13-17-52(81)64(94)78-62(43(2)85)65(95)75-42)68(98)54-19-15-34-82(54)59(89)21-9-10-30-74-71(103)76-44-22-25-47-50(37-44)72(102-70(47)100)48-26-23-45(86)38-56(48)101-57-39-46(87)24-27-49(57)72/h6,8,22-27,37-39,42-43,51-55,62,85-87H,3-5,7,9-21,28-36,40-41H2,1-2H3,(H2,73,88)(H,75,95)(H,77,93)(H,78,94)(H,91,92)(H2,74,76,103)/b8-6-/t42-,43+,51-,52-,53-,54-,55-,62-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	4.40E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312336 ((S)-5-((S)-2-((2S,3R)-1-((S)-1-((S)-2-((S)-2-(ally...) Show SMILES C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)CN(CC=C)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N(CC=C)CC(N)=O |r| Show InChI InChI=1S/C68H84N12O20S/c1-5-27-76(55(86)15-7-8-26-70-67(101)72-39-16-19-42-45(32-39)68(100-66(42)98)43-20-17-40(82)33-51(43)99-52-34-41(83)18-21-44(52)68)36-54(85)73-47(23-25-57(89)90)64(96)78-29-9-13-49(78)60(92)75-58(38(4)81)61(93)71-37(3)62(94)80-31-11-14-50(80)65(97)79-30-10-12-48(79)59(91)74-46(22-24-56(87)88)63(95)77(28-6-2)35-53(69)84/h5-6,16-21,32-34,37-38,46-50,58,81-83H,1-2,7-15,22-31,35-36H2,3-4H3,(H2,69,84)(H,71,93)(H,73,85)(H,74,91)(H,75,92)(H,87,88)(H,89,90)(H2,70,72,101)/t37-,38+,46-,47-,48-,49-,50-,58-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	4.50E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312336 ((S)-5-((S)-2-((2S,3R)-1-((S)-1-((S)-2-((S)-2-(ally...) Show SMILES C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)CN(CC=C)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N(CC=C)CC(N)=O |r| Show InChI InChI=1S/C68H84N12O20S/c1-5-27-76(55(86)15-7-8-26-70-67(101)72-39-16-19-42-45(32-39)68(100-66(42)98)43-20-17-40(82)33-51(43)99-52-34-41(83)18-21-44(52)68)36-54(85)73-47(23-25-57(89)90)64(96)78-29-9-13-49(78)60(92)75-58(38(4)81)61(93)71-37(3)62(94)80-31-11-14-50(80)65(97)79-30-10-12-48(79)59(91)74-46(22-24-56(87)88)63(95)77(28-6-2)35-53(69)84/h5-6,16-21,32-34,37-38,46-50,58,81-83H,1-2,7-15,22-31,35-36H2,3-4H3,(H2,69,84)(H,71,93)(H,73,85)(H,74,91)(H,75,92)(H,87,88)(H,89,90)(H2,70,72,101)/t37-,38+,46-,47-,48-,49-,50-,58-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	4.50E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312346 (3-((19S,21aS,26aS,32S,35S,37aS)-17-(2-amino-2-oxoe...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CC=CCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C71H90N12O18S/c1-41-65(95)83-35-15-19-54(83)68(98)82-34-13-17-52(82)62(92)76-50(27-28-60(90)91)66(96)78(39-57(72)87)30-10-6-4-3-5-7-11-31-79(40-59(89)80-32-12-16-51(80)63(93)77-61(42(2)84)64(94)74-41)67(97)53-18-14-33-81(53)58(88)20-8-9-29-73-70(102)75-43-21-24-46-49(36-43)71(101-69(46)99)47-25-22-44(85)37-55(47)100-56-38-45(86)23-26-48(56)71/h7,11,21-26,36-38,41-42,50-54,61,84-86H,3-6,8-10,12-20,27-35,39-40H2,1-2H3,(H2,72,87)(H,74,94)(H,76,92)(H,77,93)(H,90,91)(H2,73,75,102)/t41-,42+,50-,51-,52-,53-,54-,61-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	4.70E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312315 (CHEMBL1075925 | PEPTAPPEE) Show SMILES C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O |r| Show InChI InChI=1S/C42H63N9O17/c1-21(44-38(63)33(22(2)52)48-37(62)28-9-4-18-49(28)40(65)25(12-15-31(55)56)46-34(59)23-7-3-17-43-23)39(64)51-20-6-10-29(51)41(66)50-19-5-8-27(50)36(61)45-24(11-14-30(53)54)35(60)47-26(42(67)68)13-16-32(57)58/h21-29,33,43,52H,3-20H2,1-2H3,(H,44,63)(H,45,61)(H,46,59)(H,47,60)(H,48,62)(H,53,54)(H,55,56)(H,57,58)(H,67,68)/t21-,22+,23-,24-,25-,26-,27-,28-,29-,33-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL MMDB PC cid PC sid UniChem Similars	MMDB Article PubMed	n/a	n/a	n/a	5.00E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312315 (CHEMBL1075925 | PEPTAPPEE) Show SMILES C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O |r| Show InChI InChI=1S/C42H63N9O17/c1-21(44-38(63)33(22(2)52)48-37(62)28-9-4-18-49(28)40(65)25(12-15-31(55)56)46-34(59)23-7-3-17-43-23)39(64)51-20-6-10-29(51)41(66)50-19-5-8-27(50)36(61)45-24(11-14-30(53)54)35(60)47-26(42(67)68)13-16-32(57)58/h21-29,33,43,52H,3-20H2,1-2H3,(H,44,63)(H,45,61)(H,46,59)(H,47,60)(H,48,62)(H,53,54)(H,55,56)(H,57,58)(H,67,68)/t21-,22+,23-,24-,25-,26-,27-,28-,29-,33-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL MMDB PC cid PC sid UniChem Similars	MMDB Article PubMed	n/a	n/a	n/a	>5.00E+4	n/a	n/a	n/a	n/a	n/a
NCI-Frederick Curated by ChEMBL					Assay Description Binding affinity to Tsg101				ACS Med Chem Lett 2: 337-341 (2011) Article DOI: 10.1021/ml1002579 BindingDB Entry DOI: 10.7270/Q22B8ZF4
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312316 (3-((6S,9S,11aS,27S,29aS,34aS)-25-(2-amino-2-oxoeth...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCC=CCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C68H84N12O18S/c1-38-62(92)80-32-12-16-51(80)65(95)79-31-10-14-49(79)59(89)73-47(24-25-57(87)88)63(93)75(36-54(69)84)27-7-3-4-8-28-76(37-56(86)77-29-9-13-48(77)60(90)74-58(39(2)81)61(91)71-38)64(94)50-15-11-30-78(50)55(85)17-5-6-26-70-67(99)72-40-18-21-43-46(33-40)68(98-66(43)96)44-22-19-41(82)34-52(44)97-53-35-42(83)20-23-45(53)68/h3,7,18-23,33-35,38-39,47-51,58,81-83H,4-6,8-17,24-32,36-37H2,1-2H3,(H2,69,84)(H,71,91)(H,73,89)(H,74,90)(H,87,88)(H2,70,72,99)/t38-,39+,47-,48-,49-,50-,51-,58-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	5.20E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312335 ((S)-5-(allyl(2-amino-2-oxoethyl)amino)-4-((S)-1-((...) Show SMILES C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN(CC=C)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N(CC=C)CC(N)=O |r| Show InChI InChI=1S/C68H84N12O18S/c1-5-27-75(36-54(69)84)63(93)47(24-25-57(87)88)73-59(89)49-14-10-31-79(49)65(95)51-16-12-32-80(51)62(92)38(3)71-61(91)58(39(4)81)74-60(90)48-13-9-29-77(48)56(86)37-76(28-6-2)64(94)50-15-11-30-78(50)55(85)17-7-8-26-70-67(99)72-40-18-21-43-46(33-40)68(98-66(43)96)44-22-19-41(82)34-52(44)97-53-35-42(83)20-23-45(53)68/h5-6,18-23,33-35,38-39,47-51,58,81-83H,1-2,7-17,24-32,36-37H2,3-4H3,(H2,69,84)(H,71,91)(H,73,89)(H,74,90)(H,87,88)(H2,70,72,99)/t38-,39+,47-,48-,49-,50-,51-,58-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	5.30E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50230460 (5-[(1Z)-({[(2S,3S)-2-{[(1S)-1-{[(1S)-1-carbamoyl-3...) Show SMILES C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31)C(=O)N[C@@H](C)C(=O)N1CCCCC1C(=O)N1CC[C@H](O\N=C/c2ccc(O)c(c2)C(O)=O)[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(N)=O Show InChI InChI=1S/C77H91N13O26S/c1-38(71(108)89-29-6-4-9-54(89)73(110)90-32-27-56(116-80-37-40-13-23-55(94)45(33-40)74(111)112)64(90)70(107)84-50(21-25-61(98)99)66(103)83-49(65(78)102)20-24-60(96)97)81-69(106)63(39(2)91)86-68(105)53-11-8-31-88(53)72(109)51(22-26-62(100)101)85-67(104)52-10-7-30-87(52)59(95)12-3-5-28-79-76(117)82-41-14-17-44-48(34-41)77(115-75(44)113)46-18-15-42(92)35-57(46)114-58-36-43(93)16-19-47(58)77/h13-19,23,33-39,49-54,56,63-64,91-94H,3-12,20-22,24-32H2,1-2H3,(H2,78,102)(H,81,106)(H,83,103)(H,84,107)(H,85,104)(H,86,105)(H,96,97)(H,98,99)(H,100,101)(H,111,112)(H2,79,82,117)/b80-37-/t38-,39+,49-,50-,51-,52-,53-,54?,56-,63-,64-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	5.40E+4	n/a	n/a	n/a	n/a	n/a
NIH Curated by ChEMBL					Assay Description Binding affinity to Tsg101				Bioorg Med Chem Lett 18: 1096-101 (2008) Article DOI: 10.1016/j.bmcl.2007.12.003 BindingDB Entry DOI: 10.7270/Q2930V0S
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312326 (3-((6S,9S,11aS,26S,28aS,33aS)-24-(2-amino-2-oxoeth...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CC\C=C/CN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:19| Show InChI InChI=1S/C67H82N12O18S/c1-37-61(91)79-31-11-15-50(79)64(94)78-30-9-13-48(78)58(88)72-46(23-24-56(86)87)62(92)74(35-53(68)83)26-6-3-7-27-75(36-55(85)76-28-8-12-47(76)59(89)73-57(38(2)80)60(90)70-37)63(93)49-14-10-29-77(49)54(84)16-4-5-25-69-66(98)71-39-17-20-42-45(32-39)67(97-65(42)95)43-21-18-40(81)33-51(43)96-52-34-41(82)19-22-44(52)67/h3,6,17-22,32-34,37-38,46-50,57,80-82H,4-5,7-16,23-31,35-36H2,1-2H3,(H2,68,83)(H,70,90)(H,72,88)(H,73,89)(H,86,87)(H2,69,71,98)/b6-3-/t37-,38+,46-,47-,48-,49-,50-,57-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	5.70E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312350 (3,3'-((6S,22S,24aS,29aS,35S,38S,40aS)-20-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CC=CCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C71H90N12O20S/c1-40-65(97)83-34-14-17-53(83)68(100)82-33-13-15-51(82)62(94)77-49(25-27-59(90)91)66(98)80(38-56(72)87)31-11-7-5-3-4-6-10-30-79(39-57(88)76-50(26-28-60(92)93)67(99)81-32-12-16-52(81)63(95)78-61(41(2)84)64(96)74-40)58(89)18-8-9-29-73-70(104)75-42-19-22-45-48(35-42)71(103-69(45)101)46-23-20-43(85)36-54(46)102-55-37-44(86)21-24-47(55)71/h6,10,19-24,35-37,40-41,49-53,61,84-86H,3-5,7-9,11-18,25-34,38-39H2,1-2H3,(H2,72,87)(H,74,96)(H,76,88)(H,77,94)(H,78,95)(H,90,91)(H,92,93)(H2,73,75,104)/t40-,41+,49-,50-,51-,52-,53-,61-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	6.50E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312324 (3-((18S,20aS,25aS,31S,34S,36aS)-16-(2-amino-2-oxoe...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCCC\C=C/CN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:22| Show InChI InChI=1S/C70H88N12O18S/c1-40-64(94)82-34-14-18-53(82)67(97)81-33-12-16-51(81)61(91)75-49(26-27-59(89)90)65(95)77(38-56(71)86)29-9-5-3-4-6-10-30-78(39-58(88)79-31-11-15-50(79)62(92)76-60(41(2)83)63(93)73-40)66(96)52-17-13-32-80(52)57(87)19-7-8-28-72-69(101)74-42-20-23-45-48(35-42)70(100-68(45)98)46-24-21-43(84)36-54(46)99-55-37-44(85)22-25-47(55)70/h5,9,20-25,35-37,40-41,49-53,60,83-85H,3-4,6-8,10-19,26-34,38-39H2,1-2H3,(H2,71,86)(H,73,93)(H,75,91)(H,76,92)(H,89,90)(H2,72,74,101)/b9-5-/t40-,41+,49-,50-,51-,52-,53-,60-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	7.90E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312327 (3-((6S,9S,11aS,25S,27aS,32aS)-23-(2-amino-2-oxoeth...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(C\C=C/CN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:18| Show InChI InChI=1S/C66H80N12O18S/c1-36-60(90)78-30-10-14-49(78)63(93)77-29-8-12-47(77)57(87)71-45(22-23-55(85)86)61(91)73(34-52(67)82)25-5-6-26-74(35-54(84)75-27-7-11-46(75)58(88)72-56(37(2)79)59(89)69-36)62(92)48-13-9-28-76(48)53(83)15-3-4-24-68-65(97)70-38-16-19-41-44(31-38)66(96-64(41)94)42-20-17-39(80)32-50(42)95-51-33-40(81)18-21-43(51)66/h5-6,16-21,31-33,36-37,45-49,56,79-81H,3-4,7-15,22-30,34-35H2,1-2H3,(H2,67,82)(H,69,89)(H,71,87)(H,72,88)(H,85,86)(H2,68,70,97)/b6-5-/t36-,37+,45-,46-,47-,48-,49-,56-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	8.70E+4	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312333 (3,3'-((6S,9S,11aS,17S,28S,30aS,35aS)-26-(2-amino-2...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CC=CCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C66H80N12O20S/c1-35-60(92)78-29-9-12-48(78)63(95)77-28-8-10-46(77)57(89)72-44(20-22-54(85)86)61(93)75(33-51(67)82)26-6-5-25-74(34-52(83)71-45(21-23-55(87)88)62(94)76-27-7-11-47(76)58(90)73-56(36(2)79)59(91)69-35)53(84)13-3-4-24-68-65(99)70-37-14-17-40-43(30-37)66(98-64(40)96)41-18-15-38(80)31-49(41)97-50-32-39(81)16-19-42(50)66/h5-6,14-19,30-32,35-36,44-48,56,79-81H,3-4,7-13,20-29,33-34H2,1-2H3,(H2,67,82)(H,69,91)(H,71,83)(H,72,89)(H,73,90)(H,85,86)(H,87,88)(H2,68,70,99)/t35-,36+,44-,45-,46-,47-,48-,56-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	1.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312314 (3,3'-((6S,24S,26aS,31aS,37S,40S,42aS)-22-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCC\C=C/CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:29| Show InChI InChI=1S/C73H94N12O20S/c1-42-67(99)85-36-16-19-55(85)70(102)84-35-15-17-53(84)64(96)79-51(27-29-61(92)93)68(100)82(40-58(74)89)33-13-9-7-5-3-4-6-8-12-32-81(41-59(90)78-52(28-30-62(94)95)69(101)83-34-14-18-54(83)65(97)80-63(43(2)86)66(98)76-42)60(91)20-10-11-31-75-72(106)77-44-21-24-47-50(37-44)73(105-71(47)103)48-25-22-45(87)38-56(48)104-57-39-46(88)23-26-49(57)73/h4,6,21-26,37-39,42-43,51-55,63,86-88H,3,5,7-20,27-36,40-41H2,1-2H3,(H2,74,89)(H,76,98)(H,78,90)(H,79,96)(H,80,97)(H,92,93)(H,94,95)(H2,75,77,106)/b6-4-/t42-,43+,51-,52-,53-,54-,55-,63-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	1.06E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312325 (3-((6S,9S,11aS,28S,30aS,35aS)-26-(2-amino-2-oxoeth...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCCC=CCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C69H86N12O18S/c1-39-63(93)81-33-13-17-52(81)66(96)80-32-11-15-50(80)60(90)74-48(25-26-58(88)89)64(94)76(37-55(70)85)28-8-4-3-5-9-29-77(38-57(87)78-30-10-14-49(78)61(91)75-59(40(2)82)62(92)72-39)65(95)51-16-12-31-79(51)56(86)18-6-7-27-71-68(100)73-41-19-22-44-47(34-41)69(99-67(44)97)45-23-20-42(83)35-53(45)98-54-36-43(84)21-24-46(54)69/h4,8,19-24,34-36,39-40,48-52,59,82-84H,3,5-7,9-18,25-33,37-38H2,1-2H3,(H2,70,85)(H,72,92)(H,74,90)(H,75,91)(H,88,89)(H2,71,73,100)/t39-,40+,48-,49-,50-,51-,52-,59-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	1.08E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312323 (3-((19S,21aS,26aS,32S,35S,37aS)-17-(2-amino-2-oxoe...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCCCCC=CCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C71H90N12O18S/c1-41-65(95)83-35-15-19-54(83)68(98)82-34-13-17-52(82)62(92)76-50(27-28-60(90)91)66(96)78(39-57(72)87)30-10-6-4-3-5-7-11-31-79(40-59(89)80-32-12-16-51(80)63(93)77-61(42(2)84)64(94)74-41)67(97)53-18-14-33-81(53)58(88)20-8-9-29-73-70(102)75-43-21-24-46-49(36-43)71(101-69(46)99)47-25-22-44(85)37-55(47)100-56-38-45(86)23-26-48(56)71/h6,10,21-26,36-38,41-42,50-54,61,84-86H,3-5,7-9,11-20,27-35,39-40H2,1-2H3,(H2,72,87)(H,74,94)(H,76,92)(H,77,93)(H,90,91)(H2,73,75,102)/b10-6-/t41-,42+,50-,51-,52-,53-,54-,61-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	1.12E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312321 ((S)-5-amino-4-(2-((3aS,8aS,22aS,25S,28S)-16-((S)-1...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CC\C=C/CN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:19| Show InChI InChI=1S/C67H82N12O18S/c1-37-61(91)78-30-11-15-50(78)64(94)79-31-10-14-49(79)63(93)74(35-53(83)72-46(58(68)88)23-24-56(86)87)26-6-3-7-27-75(36-55(85)76-28-8-12-47(76)59(89)73-57(38(2)80)60(90)70-37)62(92)48-13-9-29-77(48)54(84)16-4-5-25-69-66(98)71-39-17-20-42-45(32-39)67(97-65(42)95)43-21-18-40(81)33-51(43)96-52-34-41(82)19-22-44(52)67/h3,6,17-22,32-34,37-38,46-50,57,80-82H,4-5,7-16,23-31,35-36H2,1-2H3,(H2,68,88)(H,70,90)(H,72,83)(H,73,89)(H,86,87)(H2,69,71,98)/b6-3-/t37-,38+,46-,47-,48-,49-,50-,57-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	1.71E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312322 ((S)-5-amino-4-(2-((3aS,8aS,21aS,24S,27S)-15-((S)-1...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(C\C=C/CN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:18| Show InChI InChI=1S/C66H80N12O18S/c1-36-60(90)77-29-10-14-49(77)63(93)78-30-9-13-48(78)62(92)73(34-52(82)71-45(57(67)87)22-23-55(85)86)25-5-6-26-74(35-54(84)75-27-7-11-46(75)58(88)72-56(37(2)79)59(89)69-36)61(91)47-12-8-28-76(47)53(83)15-3-4-24-68-65(97)70-38-16-19-41-44(31-38)66(96-64(41)94)42-20-17-39(80)32-50(42)95-51-33-40(81)18-21-43(51)66/h5-6,16-21,31-33,36-37,45-49,56,79-81H,3-4,7-15,22-30,34-35H2,1-2H3,(H2,67,87)(H,69,89)(H,71,82)(H,72,88)(H,85,86)(H2,68,70,97)/b6-5-/t36-,37+,45-,46-,47-,48-,49-,56-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	2.18E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312317 (3,3'-((6S,19S,21aS,26aS,32S,35S,37aS,Z)-17-(2-amin...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCC\C=C/CN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:29| Show InChI InChI=1S/C68H84N12O20S/c1-37-62(94)80-31-11-14-50(80)65(97)79-30-10-12-48(79)59(91)74-46(22-24-56(87)88)63(95)77(35-53(69)84)28-8-4-3-7-27-76(36-54(85)73-47(23-25-57(89)90)64(96)78-29-9-13-49(78)60(92)75-58(38(2)81)61(93)71-37)55(86)15-5-6-26-70-67(101)72-39-16-19-42-45(32-39)68(100-66(42)98)43-20-17-40(82)33-51(43)99-52-34-41(83)18-21-44(52)68/h4,8,16-21,32-34,37-38,46-50,58,81-83H,3,5-7,9-15,22-31,35-36H2,1-2H3,(H2,69,84)(H,71,93)(H,73,85)(H,74,91)(H,75,92)(H,87,88)(H,89,90)(H2,70,72,101)/b8-4-/t37-,38+,46-,47-,48-,49-,50-,58-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312318 ((S)-5-amino-4-(2-((6S,9S,11aS,29aS,34aS)-18-((S)-1...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCCCC\C=C\CN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,t:23| Show InChI InChI=1S/C71H90N12O18S/c1-41-65(95)82-34-15-19-54(82)68(98)83-35-14-18-53(83)67(97)78(39-57(87)76-50(62(72)92)27-28-60(90)91)30-10-6-4-3-5-7-11-31-79(40-59(89)80-32-12-16-51(80)63(93)77-61(42(2)84)64(94)74-41)66(96)52-17-13-33-81(52)58(88)20-8-9-29-73-70(102)75-43-21-24-46-49(36-43)71(101-69(46)99)47-25-22-44(85)37-55(47)100-56-38-45(86)23-26-48(56)71/h6,10,21-26,36-38,41-42,50-54,61,84-86H,3-5,7-9,11-20,27-35,39-40H2,1-2H3,(H2,72,92)(H,74,94)(H,76,87)(H,77,93)(H,90,91)(H2,73,75,102)/b10-6+/t41-,42+,50-,51-,52-,53-,54-,61-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312319 ((S)-5-amino-4-(2-((6S,9S,11aS,28aS,33aS)-18-((S)-1...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCCC\C=C/CN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:22| Show InChI InChI=1S/C70H88N12O18S/c1-40-64(94)81-33-14-18-53(81)67(97)82-34-13-17-52(82)66(96)77(38-56(86)75-49(61(71)91)26-27-59(89)90)29-9-5-3-4-6-10-30-78(39-58(88)79-31-11-15-50(79)62(92)76-60(41(2)83)63(93)73-40)65(95)51-16-12-32-80(51)57(87)19-7-8-28-72-69(101)74-42-20-23-45-48(35-42)70(100-68(45)98)46-24-21-43(84)36-54(46)99-55-37-44(85)22-25-47(55)70/h5,9,20-25,35-37,40-41,49-53,60,83-85H,3-4,6-8,10-19,26-34,38-39H2,1-2H3,(H2,71,91)(H,73,93)(H,75,86)(H,76,92)(H,89,90)(H2,72,74,101)/b9-5-/t40-,41+,49-,50-,51-,52-,53-,60-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312320 ((S)-5-amino-4-(2-((6S,9S,11aS,27aS,32aS)-18-((S)-1...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCC\C=C\CN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,t:21| Show InChI InChI=1S/C69H86N12O18S/c1-39-63(93)80-32-13-17-52(80)66(96)81-33-12-16-51(81)65(95)76(37-55(85)74-48(60(70)90)25-26-58(88)89)28-8-4-3-5-9-29-77(38-57(87)78-30-10-14-49(78)61(91)75-59(40(2)82)62(92)72-39)64(94)50-15-11-31-79(50)56(86)18-6-7-27-71-68(100)73-41-19-22-44-47(34-41)69(99-67(44)97)45-23-20-42(83)35-53(45)98-54-36-43(84)21-24-46(54)69/h4,8,19-24,34-36,39-40,48-52,59,82-84H,3,5-7,9-18,25-33,37-38H2,1-2H3,(H2,70,90)(H,72,92)(H,74,85)(H,75,91)(H,88,89)(H2,71,73,100)/b8-4+/t39-,40+,48-,49-,50-,51-,52-,59-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312351 ((S)-5-amino-4-(2-((6S,21aS,26aS,32S,35S,37aS)-6-(2...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(C\C=C/CCCCCCN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:27| Show InChI InChI=1S/C71H90N12O20S/c1-40-65(97)82-33-14-17-53(82)68(100)83-34-13-16-52(83)67(99)80(39-57(88)76-49(62(72)94)25-27-59(90)91)31-11-7-5-3-4-6-10-30-79(38-56(87)77-50(26-28-60(92)93)66(98)81-32-12-15-51(81)63(95)78-61(41(2)84)64(96)74-40)58(89)18-8-9-29-73-70(104)75-42-19-22-45-48(35-42)71(103-69(45)101)46-23-20-43(85)36-54(46)102-55-37-44(86)21-24-47(55)71/h6,10,19-24,35-37,40-41,49-53,61,84-86H,3-5,7-9,11-18,25-34,38-39H2,1-2H3,(H2,72,94)(H,74,96)(H,76,88)(H,77,87)(H,78,95)(H,90,91)(H,92,93)(H2,73,75,104)/b10-6-/t40-,41+,49-,50-,51-,52-,53-,61-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312344 ((S)-5-amino-4-(2-((3aS,8aS,23aS,26S,29S)-17-((S)-1...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CN(CCCC=CCN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C68H84N12O18S/c1-38-62(92)79-31-12-16-51(79)65(95)80-32-11-15-50(80)64(94)75(36-54(84)73-47(59(69)89)24-25-57(87)88)27-7-3-4-8-28-76(37-56(86)77-29-9-13-48(77)60(90)74-58(39(2)81)61(91)71-38)63(93)49-14-10-30-78(49)55(85)17-5-6-26-70-67(99)72-40-18-21-43-46(33-40)68(98-66(43)96)44-22-19-41(82)34-52(44)97-53-35-42(83)20-23-45(53)68/h3,7,18-23,33-35,38-39,47-51,58,81-83H,4-6,8-17,24-32,36-37H2,1-2H3,(H2,69,89)(H,71,91)(H,73,84)(H,74,90)(H,87,88)(H2,70,72,99)/t38-,39+,47-,48-,49-,50-,51-,58-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312328 ((S)-5-amino-4-(2-((6S,20aS,25aS,31S,34S,36aS)-6-(2...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCCC\C=C\CN(CC(=O)N[C@@H](CCC(O)=O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,t:31| Show InChI InChI=1S/C70H88N12O20S/c1-39-64(96)81-32-13-16-52(81)67(99)82-33-12-15-51(82)66(98)79(38-56(87)75-48(61(71)93)24-26-58(89)90)30-10-6-4-3-5-9-29-78(37-55(86)76-49(25-27-59(91)92)65(97)80-31-11-14-50(80)62(94)77-60(40(2)83)63(95)73-39)57(88)17-7-8-28-72-69(103)74-41-18-21-44-47(34-41)70(102-68(44)100)45-22-19-42(84)35-53(45)101-54-36-43(85)20-23-46(54)70/h6,10,18-23,34-36,39-40,48-52,60,83-85H,3-5,7-9,11-17,24-33,37-38H2,1-2H3,(H2,71,93)(H,73,95)(H,75,87)(H,76,86)(H,77,94)(H,89,90)(H,91,92)(H2,72,74,103)/b10-6+/t39-,40+,48-,49-,50-,51-,52-,60-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312329 (3,3'-((6S,22S,24aS,29aS,35S,38S,40aS,Z)-20-(2-amin...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCCCC\C=C/CN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:32| Show InChI InChI=1S/C71H90N12O20S/c1-40-65(97)83-34-14-17-53(83)68(100)82-33-13-15-51(82)62(94)77-49(25-27-59(90)91)66(98)80(38-56(72)87)31-11-7-5-3-4-6-10-30-79(39-57(88)76-50(26-28-60(92)93)67(99)81-32-12-16-52(81)63(95)78-61(41(2)84)64(96)74-40)58(89)18-8-9-29-73-70(104)75-42-19-22-45-48(35-42)71(103-69(45)101)46-23-20-43(85)36-54(46)102-55-37-44(86)21-24-47(55)71/h7,11,19-24,35-37,40-41,49-53,61,84-86H,3-6,8-10,12-18,25-34,38-39H2,1-2H3,(H2,72,87)(H,74,96)(H,76,88)(H,77,94)(H,78,95)(H,90,91)(H,92,93)(H2,73,75,104)/b11-7-/t40-,41+,49-,50-,51-,52-,53-,61-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312330 (3,3'-((6S,21S,23aS,28aS,34S,37S,39aS)-19-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCCC\C=C/CN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:31| Show InChI InChI=1S/C70H88N12O20S/c1-39-64(96)82-33-13-16-52(82)67(99)81-32-12-14-50(81)61(93)76-48(24-26-58(89)90)65(97)79(37-55(71)86)30-10-6-4-3-5-9-29-78(38-56(87)75-49(25-27-59(91)92)66(98)80-31-11-15-51(80)62(94)77-60(40(2)83)63(95)73-39)57(88)17-7-8-28-72-69(103)74-41-18-21-44-47(34-41)70(102-68(44)100)45-22-19-42(84)35-53(45)101-54-36-43(85)20-23-46(54)70/h6,10,18-23,34-36,39-40,48-52,60,83-85H,3-5,7-9,11-17,24-33,37-38H2,1-2H3,(H2,71,86)(H,73,95)(H,75,87)(H,76,93)(H,77,94)(H,89,90)(H,91,92)(H2,72,74,103)/b10-6-/t39-,40+,48-,49-,50-,51-,52-,60-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312331 (3,3'-((6S,20S,22aS,27aS,33S,36S,38aS)-18-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCCC\C=C/CN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r,c:30| Show InChI InChI=1S/C69H86N12O20S/c1-38-63(95)81-32-12-15-51(81)66(98)80-31-11-13-49(80)60(92)75-47(23-25-57(88)89)64(96)78(36-54(70)85)29-9-5-3-4-8-28-77(37-55(86)74-48(24-26-58(90)91)65(97)79-30-10-14-50(79)61(93)76-59(39(2)82)62(94)72-38)56(87)16-6-7-27-71-68(102)73-40-17-20-43-46(33-40)69(101-67(43)99)44-21-18-41(83)34-52(44)100-53-35-42(84)19-22-45(53)69/h5,9,17-22,33-35,38-39,47-51,59,82-84H,3-4,6-8,10-16,23-32,36-37H2,1-2H3,(H2,70,85)(H,72,94)(H,74,86)(H,75,92)(H,76,93)(H,88,89)(H,90,91)(H2,71,73,102)/b9-5-/t38-,39+,47-,48-,49-,50-,51-,59-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312332 (3,3'-((6S,18S,20aS,25aS,31S,34S,36aS)-16-(2-amino-...) Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)CN(CCC=CCN(CC(N)=O)C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O)C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31 |r| Show InChI InChI=1S/C67H82N12O20S/c1-36-61(93)79-30-10-13-49(79)64(96)78-29-9-11-47(78)58(90)73-45(21-23-55(86)87)62(94)76(34-52(68)83)27-7-3-6-26-75(35-53(84)72-46(22-24-56(88)89)63(95)77-28-8-12-48(77)59(91)74-57(37(2)80)60(92)70-36)54(85)14-4-5-25-69-66(100)71-38-15-18-41-44(31-38)67(99-65(41)97)42-19-16-39(81)32-50(42)98-51-33-40(82)17-20-43(51)67/h3,7,15-20,31-33,36-37,45-49,57,80-82H,4-6,8-14,21-30,34-35H2,1-2H3,(H2,68,83)(H,70,92)(H,72,84)(H,73,90)(H,74,91)(H,86,87)(H,88,89)(H2,69,71,100)/t36-,37+,45-,46-,47-,48-,49-,57-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	>5.00E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair
Tumor susceptibility gene 101 protein (Homo sapiens (Human))	BDBM50312334 ((S)-4-(2-((S)-N-allyl-1-((S)-1-((S)-2-((2S,3R)-2-(...) Show SMILES C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN(CC=C)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2C(=O)OC3(c2c1)c1ccc(O)cc1Oc1cc(O)ccc31)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N(CC=C)CC(=O)N[C@@H](CCC(O)=O)C(N)=O |r| Show InChI InChI=1S/C68H84N12O18S/c1-5-27-75(36-54(84)73-47(59(69)89)24-25-57(87)88)64(94)50-15-11-32-80(50)65(95)51-16-12-31-79(51)62(92)38(3)71-61(91)58(39(4)81)74-60(90)48-13-9-29-77(48)56(86)37-76(28-6-2)63(93)49-14-10-30-78(49)55(85)17-7-8-26-70-67(99)72-40-18-21-43-46(33-40)68(98-66(43)96)44-22-19-41(82)34-52(44)97-53-35-42(83)20-23-45(53)68/h5-6,18-23,33-35,38-39,47-51,58,81-83H,1-2,7-17,24-32,36-37H2,3-4H3,(H2,69,89)(H,71,91)(H,73,84)(H,74,90)(H,87,88)(H2,70,72,99)/t38-,39+,47-,48-,49-,50-,51-,58-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	5.90E+5	n/a	n/a	n/a	n/a	n/a
National Cancer Institute-Frederick Curated by ChEMBL					Assay Description Binding affinity to ubiquitin E2 variant domain of human Tsg101 by fluorescent anisotropy				Bioorg Med Chem Lett 20: 318-21 (2010) Article DOI: 10.1016/j.bmcl.2009.10.105 BindingDB Entry DOI: 10.7270/Q2HH6K6F
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 111 total )  |  Next  |  Last  >>

Jump to: